80 related articles for article (PubMed ID: 20010503)
1. Complete objective response of neuroblastoma to biological treatment.
Di Bella G; Colori B
Neuro Endocrinol Lett; 2009; 30(4):437-49. PubMed ID: 20010503
[TBL] [Abstract][Full Text] [Related]
2. Complete objective response of oesophageal squamocellular carcinoma to biological treatment.
Di Bella G; Madarena M
Neuro Endocrinol Lett; 2009; 30(3):312-21. PubMed ID: 19855352
[TBL] [Abstract][Full Text] [Related]
3. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 23 tumours of the head and neck.
Di Bella G; Colori B
Neuro Endocrinol Lett; 2012; 33(3):249-56. PubMed ID: 22635078
[TBL] [Abstract][Full Text] [Related]
4. Congenital fibrosarcoma in complete remission with Somatostatin, Bromocriptine, Retinoids, Vitamin D3, Vitamin E, Vitamin C, Melatonin, Calcium, Chondroitin sulfate associated with low doses of Cyclophosphamide in a 14-year Follow up.
Di Bella G; Toscano R; Ricchi A; Colori B
Neuro Endocrinol Lett; 2015; 36(8):725-33. PubMed ID: 26921571
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin, retinoids, melatonin, vitamin D, bromocriptine, and cyclophosphamide in chemotherapy-pretreated patients with advanced lung adenocarcinoma and low performance status.
Norsa A; Martino V
Cancer Biother Radiopharm; 2007 Feb; 22(1):50-5. PubMed ID: 17627413
[TBL] [Abstract][Full Text] [Related]
6. Complete objective response, stable for 5 years, with the Di Bella Method, of multiple-metastatic carcinoma of the breast.
Di Bella G; Colori B; Toscano R
Neuro Endocrinol Lett; 2017 Dec; 38(6):401-407. PubMed ID: 29298280
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin, retinoids, melatonin, vitamin D, bromocriptine, and cyclophosphamide in advanced non-small-cell lung cancer patients with low performance status.
Norsa A; Martino V
Cancer Biother Radiopharm; 2006 Feb; 21(1):68-73. PubMed ID: 16480333
[TBL] [Abstract][Full Text] [Related]
8. Complete objective response to biological therapy of plurifocal breast carcinoma.
Di Bella G
Neuro Endocrinol Lett; 2008 Dec; 29(6):857-66. PubMed ID: 19112416
[TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide plus somatostatin, bromocriptin, retinoids, melatonin and ACTH in the treatment of low-grade non-Hodgkin's lymphomas at advanced stage: results of a phase II trial.
Todisco M; Casaccia P; Rossi N
Cancer Biother Radiopharm; 2001 Apr; 16(2):171-7. PubMed ID: 11385964
[TBL] [Abstract][Full Text] [Related]
10. Chronic lymphocytic leukemia: long-lasting remission with combination of cyclophosphamide, somatostatin, bromocriptine, retinoids, melatonin, and ACTH.
Todisco M
Cancer Biother Radiopharm; 2009 Jun; 24(3):353-5. PubMed ID: 19538058
[TBL] [Abstract][Full Text] [Related]
11. Neuroblastoma in the adult. Case report.
Zerrweck-López C; Quijano-Orvañanos F; Montañez-Ramírez H; Murillo-Zolezzi A; Toledo-Valdovinos S; Padilla-Longoria R
Cir Cir; 2009; 77(5):397-401. PubMed ID: 19944030
[TBL] [Abstract][Full Text] [Related]
12. Improved management of stage III neuroblastoma.
Dy V; Watson RC; Exelby PR; Hajdu SI; Helson L
Clin Bull; 1979; 9(2):76-81. PubMed ID: 519856
[No Abstract] [Full Text] [Related]
13. Neuroblastoma.
Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
[TBL] [Abstract][Full Text] [Related]
14. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer.
Di Bella G
Neuro Endocrinol Lett; 2011; 32(6):751-62. PubMed ID: 22167148
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the safety and efficacy of the first-line treatment with somatostatin combined with melatonin, retinoids, vitamin D3, and low doses of cyclophosphamide in 20 cases of breast cancer: a preliminary report.
Di Bella G; Mascia F; Ricchi A; Colori B
Neuro Endocrinol Lett; 2013; 34(7):660-8. PubMed ID: 24464005
[TBL] [Abstract][Full Text] [Related]
16. Retroperitoneal mass with intradural extension: value of magnetic resonance imaging in neuroblastoma.
Dietrich RB; Kangarloo H
AJR Am J Roentgenol; 1986 Feb; 146(2):251-4. PubMed ID: 3510512
[No Abstract] [Full Text] [Related]
17. Low-grade non-Hodgkin lymphoma at advanced stage: a case successfully treated with cyclophosphamide plus somatostatin, bromocriptine, retinoids, and melatonin.
Todisco M
Am J Ther; 2007; 14(1):113-5. PubMed ID: 17303979
[TBL] [Abstract][Full Text] [Related]
18. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
[TBL] [Abstract][Full Text] [Related]
19. [Importance of gammagraphy using 131I-metaiodobenzylguanidine in the follow-up of neuroblastomas. Apropos of a case].
Ferris Tortajada J; Caballero Carpena O; Verdeguer Miralles A; Esquembre Menor C; Castel Sánchez V
An Esp Pediatr; 1986 Sep; 25(3):209-11. PubMed ID: 3789554
[No Abstract] [Full Text] [Related]
20. [Value of polychemotherapy in the treatment of children with neuroblastoma].
Czerwiński W; Jurczyk-Procyk S; Ordyniec J; Perek D
Probl Med Wieku Rozwoj; 1981; 10():177-87. PubMed ID: 6760183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
